Insiders · INDV

Mark Stejbach

Director at Indivior Pharmaceuticals, Inc. (INDV) since January 2026

Mark Stejbach has filed 6 insider reports with the SEC since June 2021, as director at Indivior Pharmaceuticals, Inc. (INDV) and director at Flexion Therapeutics Inc (FLXN). In the last 12 months Mark Stejbach bought $27.4K of stock on the open market. The latest filing, on May 14, 2026, reports grant or award at Indivior Pharmaceuticals, Inc. (INDV).

Filings
6
Companies
2
Bought on market
$27.4K
Sold on market
None

Companies where Mark Stejbach is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Indivior Pharmaceuticals, Inc. logo
INDV
Indivior Pharmaceuticals, Inc.
Directorsince January 202627,087$27.4K$35.39$36.28+2.5%May 14, 2026
Flexion Therapeutics Inc logo
FLXN
Flexion Therapeutics Inc
Director0$23.5614Nov 19, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Mark Stejbach with

Other insiders at the same companies

Questions about Mark Stejbach

What is Mark Stejbach's role at Indivior Pharmaceuticals, Inc.?
Mark Stejbach reports to the SEC as director at Indivior Pharmaceuticals, Inc. (INDV), according to the latest filing on May 14, 2026. Mark Stejbach has also filed as director at Flexion Therapeutics Inc (FLXN).
How many shares does Mark Stejbach own?
After the latest filing that states it, Mark Stejbach directly owned 27,087 shares of Indivior Pharmaceuticals, Inc. (INDV). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark Stejbach bought or sold stock recently?
The most recent open-market purchase was on January 5, 2026: bought 775 shares of Indivior PLC (INDV) for $27.4K at an average of $35.39.
How do I get alerts when Mark Stejbach files?
Follow Mark Stejbach on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Mark Stejbach (SEC CIK 0001487937). Totals count each trade once, skipping amendments whose original is on file, from Jun 28, 2021 on. View on SEC EDGAR